Zemcelpro® receives EC authorization as the first and only cell therapy for blood cancer patients without access to suitable donor cells

ExCellThera Quebec Europe

View original content:https://www.prnewswire.co.uk/news-releases/zemcelpro-um171-cell-therapy-receives-ec-authorization-as-the-first-and-only-cell-therapy-for-blood-cancer-patients-without-access-to-suitable-donor-cells-302539246.html